BUY CREDITACCESS GRAMEEN LIMITED — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)29 Oct 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · same horizon·1 Jul · 5d ago
CreditAccess Grameen Limited raised INR 425 crore via private placement of NCDs. The issuance included INR 325 crore arranged by Nuvama Fixed Income Advisory and INR 100 crore placed with Bajaj Financ
NSE · Press Release·28 Jun · 1w ago
CreditAccess Grameen Limited has successfully raised INR 425 crore via private placement of non-convertible debentures (NCDs). The issuance comprised of two transactions: INR 325 crore arranged by Nuv
BSE · Company Update·28 Jun · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on CREDITACCESS GRAMEEN
- BUY — Sudeep Shah, SBICAP Securities11 Sept 2026 · ~2 weeks · target ₹1,500 · SL hit
- BUY — Motilal Oswal25 Aug 2026 · ~1 year · target ₹1,880 · Active
- BUY — Sudeep Shah, SBICAP Securities13 Aug 2026 · ~2 weeks · target ₹1,700 · SL hit
- BUY — Rakesh Bansal12 Aug 2026 · ~3 months · target ₹1,650 · Active
- BUY — Kavita Jain, Arihant Capital Markets31 Jul 2026 · ~2 weeks · target ₹1,670 · SL hit
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

